Seeing Is Believing

Currently out of the existing stock ratings of Elmar Kraus, 14 are a HOLD (40%), 20 are a BUY (57.14%), 1 are a SELL (2.86%).
Analyst Elmar Kraus, carries an average stock price target met ratio of 87.5% that have a potential upside of 24.03% achieved within 370 days. Previously, Elmar Kraus worked at DZ BANK.
Elmar Kraus’s has documented 69 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 13-Feb-2025.
Analyst best performing recommendations are on AZN (ASTRAZENECA PLC ADR).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 2/11/2022. The price target of $124.66 was fulfilled within 46 days with a profit of $21.5 (20.84%) receiving and performance score of 4.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-May-2026
$305
$56.65 (22.81%)
$245
Buy Since 09-Feb-2026
$300
$51.65 (20.80%)
$260
9 days ago
(02-Nov-2026)
12/17 (70.59%)
$50.99 (20.48%)
334
Hold Since 13-Feb-2025
$238
$-10.35 (-4.17%)
$231
13 days ago
(29-Oct-2026)
42/72 (58.33%)
$-11.65 (-4.67%)
297
Buy Since 04-May-2022
$272
$23.65 (9.52%)
$256
13 days ago
(29-Oct-2026)
59/89 (66.29%)
$22.35 (8.95%)
179
Buy Since 07-Jun-2023
$290
$41.65 (16.77%)
$250
13 days ago
(29-Oct-2026)
25/35 (71.43%)
$40.35 (16.16%)
192